type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients, both sexes, older than 18 years; diabetic patients, regardless of priority, according to the protocol defined in the study; patients diagnosed with type 2 diabetes mellitus, with any level of glycemic control measured by glycated hemoglobin and/or fasting glucose, who meet criteria for referral from primary care to specialized care; patients on insulin with glycated hemoglobin greater than 8
Exclusion criteria
Exclusion criteria: Patients under 18 years of age and Type 1 diabetes mellitus; patients with gestational diabetes mellitus or diagnosed during pregnancy; Patients with estimated or measured creatinine clearance below 30 ml / min / m2
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| To evaluate changes in fasting blood glucose levels in patients with type 2 diabetes mellitus ;To evaluate changes in urea and creatinine levels in patients with type 2 diabetes mellitus ;To evaluate the levels of cholesterol, triglycerides, HDL cholesterol and serum LDL cholesterol in patients with type 2 diabetes mellitus ;To evaluate changes in systolic and diastolic pressure measurements, measured in UBS / office ;To assess changes in body weight and BMI measures ;To evaluate the incidence of hypoglycemia events ;Assess the incidence of adverse events ;To evaluate the use of teleconsultation as a service strategy for the control of type 2 DM ;To evaluate the satisfaction of health professionals working in the UBSs participating in the study, through a structured questionnaire. ;To evaluate the patients' satisfaction with the consultations by videoconference, through a structured questionnaire ;To evaluate the quality of life of the patients by the EQ-5D quality of life questionnaire specific to DM patients;To estimate the real cost of the teleconsultation service, through the TDABC (Time-driven Activity-based Costing) micro-accounting method way to obtain the unit cost of the teleconsultation and to analyze the productive capacity of the UBS in a real-world scenario | — |
Primary
| Measure | Time frame |
|---|---|
| The alternative non-inferiority hypothesis will be accepted if the upper limit of the 95% confidence interval of the difference in HbA1c means of the teleconsultation group in relation to the presence group is higher than 0.8%, assuming that the two groups will have reductions in the value of HbA1c after the query in relation to its base value | — |
Countries
Brazil
Contacts
Hospital Alemão Oswaldo Cruz;Hospital Alemão Oswaldo Cruz